Evidence for the "stress test" theory suggests that women with a history of preeclampsia, spontaneous abortion, preterm delivery, or delivery of a low birthweight infant are at increased risk for future disease. Knowing this in advance could allow physicians to address the problems women may face early enough so that they can still benefit from lifestyle and pharmacologic interventions.
With the exception of gestational diabetes, conventional wisdom has long held that pregnancy complications were not associated with maternal disease later in life. With that in mind, research focused on the link between adult-onset chronic diseases such as cardiovascular disease (CVD) and diabetes and fetal disorders like intrauterine growth restriction and macrosomia (the "fetal programming" hypothesis).1 New research, however, has found a connection between pregnancy complications and later-life maternal disease, which suggests that pregnancy may be a "stress test" that might unmask pre- and subclinical illnesses that manifest later in life.2
Can pregnancy complications cause maternal disease later in life?
Proposed explanations
The second proposed explanation is that pregnancy-specific pathologic events result in damage or disease (Figure 1, center). This hypothesis, for instance, predicts that preeclampsia causes permanent changes in blood pressure, lipid metabolism, and endothelial function. Over time, this hastens or promotes atherosclerotic changes, which means that preeclampsia would be a direct cause of later-life cardiovascular events.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More